1.【生化】肾素;高血压蛋白原酶
1.an enzyme released by the kidneys that breaks down proteins and helps regulate blood pressure
1.Their results revealed that the protein is oxidised and changes shape to permit ready access to angiotensinogen by an enzyme, renin.
结果显示这种蛋白被一种叫肾素的酶氧化后改变形态以接近血管紧张素原。
2.Direct renin inhibitionwithaliskiren therefore represents an effective option for the long-term treatment ofessentialhypertension.
直接肾素抑制剂阿利吉仑可以坐位原发性高血压长期治疗的有效选择。
3.Plasma renin activity; Aldosterone; Malignant hypertensive arteriolar nephrosclerosis; Diagnosis.
血浆肾素活性；醛固酮；恶性高血压性小动脉性肾硬化；诊断。
4.Inhibitors of the renin-angiotensin-aldosterone system may reduce LV mass to a greater extent than other antihypertensive agents.
与其它抗高血压药物相比，肾素-血管紧张素-醛固酮系统抑制剂可以明显减低左室重量。
5.The influence of contrast material on renal venous renin activity was evaluated in a prospective study of 20 hypertensive patients .
我们对20例高血压患者作了前瞻性研究，以评定造影剂对肾静脉肾素活性的影响。
6.Renin cuts off the tail of the protein to release the hormone angiotensin, which then raises blood pressure.
肾素切断该蛋白的尾巴以释放血管紧张素，使血压升高。
7.It blocks that part of the renin-angiotensin-aldosterone hormonal system that narrows (constricts) the peripheral arteries.
一方面，它可以阻断肾素-血管紧缩素-醛固酮的激素系统，该系统会引起周围动脉的狭窄。
8.International Circulation: What about direct renin inhibition and its effect on cardiorenal protection?
《国际循环》：直接的肾素抑制剂是如何发挥心肾保护作用的？
9.Aliskiren represents a new principle of blocking the RAAS, inhibiting renin directly and acting at the rate-limiting step.
阿利吉仑代表一种阻滞RAAS的新原理，直接抑制肾素并作用于限速阶段。
10.Genes may be involved in the renin and angiotensin system, insulin resistance, sodium sensitivity, and body weight.
可能有关的基因牵涉到肾素与血管紧张素系统、对胰岛素抗拒、对钠敏感、以及体重。